Stock Scorecard
Stock Summary for Nanobiotix (NBTX) - $3.56 as of 3/28/2025 2:44:16 AM EST
Total Score
11 out of 30
Safety Score
2 out of 100
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for NBTX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NBTX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NBTX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NBTX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NBTX (2 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 0 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for NBTX
Financial Details for NBTX
Company Overview |
|
|---|---|
| Ticker | NBTX |
| Company Name | Nanobiotix |
| Country | USA |
| Description | Nanobiotix SA, a clinical-stage biotechnology, is focused on the development of candidate products for the treatment of cancer. The company is headquartered in Paris, France. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | 5/20/2025 |
Stock Price History |
|
| Last Day Price | 3.56 |
| Price 4 Years Ago | 8.10 |
| Last Day Price Updated | 3/28/2025 2:44:16 AM EST |
| Last Day Volume | 2,866 |
| Average Daily Volume | 12,406 |
| 52-Week High | 7.51 |
| 52-Week Low | 2.76 |
| Last Price to 52 Week Low | 28.99% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 37.01 |
| Sector PE | 40.10 |
| 5-Year Average PE | -28.82 |
| Free Cash Flow Ratio | 2.54 |
| Industry Free Cash Flow Ratio | 11.91 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 1.42 |
| Total Cash Per Share | 1.40 |
| Book Value Per Share Most Recent Quarter | -0.46 |
| Price to Book Ratio | 65.02 |
| Industry Price to Book Ratio | 8.86 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 4.11 |
| Industry Price to Sales Ratio Twelve Trailing Months | 88.85 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 47,404,700 |
| Market Capitalization | 168,760,732 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 30.40% |
| Reported EPS 12 Trailing Months | -0.80 |
| Reported EPS Past Year | -0.52 |
| Reported EPS Prior Year | -0.52 |
| Net Income Twelve Trailing Months | -67,372,500 |
| Net Income Past Year | -39,700,000 |
| Net Income Prior Year | -57,043,000 |
| Quarterly Revenue Growth YOY | 182.10% |
| 5-Year Revenue Growth | 215.41% |
| Operating Margin Twelve Trailing Months | -253.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 66,334,999 |
| Total Cash Past Year | 75,283,000 |
| Total Cash Prior Year | 41,388,000 |
| Net Cash Position Most Recent Quarter | 24,674,999 |
| Net Cash Position Past Year | 33,623,000 |
| Long Term Debt Past Year | 41,660,000 |
| Long Term Debt Prior Year | 44,040,000 |
| Total Debt Most Recent Quarter | 41,660,000 |
| Equity to Debt Ratio Past Year | -0.05 |
| Equity to Debt Ratio Most Recent Quarter | -1.10 |
| Total Stockholder Equity Past Year | -1,844,000 |
| Total Stockholder Equity Prior Year | -27,045,000 |
| Total Stockholder Equity Most Recent Quarter | -21,777,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 866,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.02 |
| Free Cash Flow Past Year | -12,813,000 |
| Free Cash Flow Prior Year | -37,197,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.02 |
| MACD Signal | 0.01 |
| 20-Day Bollinger Lower Band | 2.71 |
| 20-Day Bollinger Middle Band | 3.41 |
| 20-Day Bollinger Upper Band | 4.11 |
| Beta | 1.38 |
| RSI | 51.06 |
| 50-Day SMA | 5.16 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 6.47 |
System |
|
| Modified | 3/28/2025 2:44:17 AM EST |